Original from: 360DX
The US Food and Drug Administration this week granted Emergency Use Authorization for a molecular SARS-CoV-2 test from Predicine.
The Predicine SARS-CoV-2 RT-PCR Test is designed to detect viral nucleic acid in anterior nasal specimens collected dry from individuals with or without COVID-19 symptoms using the Predicine COVID-19 Collection Kit. The test is also authorized for use with samples collected at home and with pooled samples containing up to eight specimens.
The test may only be performed by Hayward, California-based Predicine, according to the FDA.
Source: FDA Grants Emergency Use Authorization for Predicine COVID-19 Test
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.